Invea Therapeutics Files for IPO
By Ben Glickman Invea Therapeutics has filed for an initial public offering with the Securities and Exchange Commission. The Guilford, Conn.-based company is...
Krishnan Nandabalan Ben Glickman Exchange Commission Nasdaq Global Market Executive Krishnan Nandabalan Alphameld Platform
Source: marketwatch.com